Back to 
RTW Investments, LP
RTW Investments, LP
ARWR
Showing 3 of 8 quarters
Position history for RTW Investments, LP's holdings in Arrowhead Pharmaceuticals, Inc.
No. RTW Investments exited its ARWR (Arrowhead Pharmaceuticals) position in Q2 2026. Its Q1 2026 13F listed 585,682 shares worth $36.7M. RTW Investments already held ARWR in its Q1 2019 13F, the earliest on record, and held it in 5 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$38.8M
Total Shares Change
-584,716
Quarter-by-Quarter History